AMEX · ELMD
Healthcare · Medical - Devices
$39.45
Down-$0.55 (-1.38%)
Updated Aug 22, 2026, 1:07 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
ELMD closed at $39.45 after 21 trading sessions, up 2.71% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $40.00 | $40.715 | $39.26 | $39.45 | 157.1K |
| Aug 20, 2026 | $40.47 | $40.47 | $39.67 | $40.00 | 40.03K |
| Aug 19, 2026 | $41.52 | $41.9999 | $40.49 | $40.87 | 37.57K |
| Aug 18, 2026 | $40.20 | $41.715 | $40.20 | $41.42 | 66.19K |
| Aug 17, 2026 | $41.19 | $41.19 | $39.52 | $40.23 | 77.97K |
| Aug 14, 2026 | $42.69 | $43.2199 | $40.915 | $41.22 | 58.68K |
| Aug 13, 2026 | $42.85 | $43.74 | $42.35 | $42.54 | 67.61K |
| Aug 12, 2026 | $42.37 | $42.85 | $41.59 | $42.48 | 39.83K |
| Aug 11, 2026 | $42.58 | $42.81 | $41.43 | $42.39 | 40.06K |
| Aug 10, 2026 | $41.90 | $42.74 | $41.422 | $42.58 | 55.06K |
| Aug 7, 2026 | $41.85 | $42.65 | $41.40 | $42.19 | 76.25K |
| Aug 6, 2026 | $41.96 | $42.26 | $41.4487 | $42.04 | 61.23K |
| Aug 5, 2026 | $42.33 | $42.33 | $41.32 | $41.87 | 45.29K |
| Aug 4, 2026 | $41.68 | $43.4751 | $41.24 | $42.16 | 64.72K |
| Aug 3, 2026 | $41.20 | $42.41 | $41.145 | $41.58 | 76.47K |
| Jul 31, 2026 | $40.00 | $41.20 | $39.65 | $40.73 | 53.53K |
| Jul 30, 2026 | $39.98 | $40.67 | $39.77 | $40.27 | 54.01K |
| Jul 29, 2026 | $39.48 | $40.98 | $39.0405 | $40.16 | 57.57K |
| Jul 28, 2026 | $40.23 | $41.02 | $38.99 | $39.48 | 91.16K |
| Jul 27, 2026 | $38.43 | $40.06 | $38.40 | $39.86 | 65.01K |
| Jul 24, 2026 | $38.32 | $39.16 | $37.75 | $38.41 | 67.34K |
The latest Smart Investors Daily articles mentioning ELMD.
ELMD research
Company profile and research snapshot.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 13, 2026 | B. Riley Securities | Buy | — |
| Nov 13, 2025 | Roth Capital | Buy | — |
| Aug 27, 2025 | Roth Capital | Buy | — |
| Jul 22, 2025 | Roth Capital | Buy | — |
| Feb 20, 2025 | B. Riley Securities | Buy | — |
No generated briefing is available yet.
Yahoo · Jun 19, 2026
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
SeekingAlpha · Jun 13, 2026
Electromed benefits from a new CMS rule and a recently approved bronchiectasis drug, driving increased disease awareness. Find out why ELMD stock is a buy.
SeekingAlpha · Feb 23, 2026
Benzinga · Feb 11, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ELMD.
